GlassScriptPhysician profile
Mark C Wyers
NPI 1811909740
$5,884.96
in general payments reported to CMS, 2019-2025
14 companies · $603 in 2025
The $603 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2021: $3,132 · 2022: $283 · 2023: $746 · 2024: $851 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,200.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,011.31 | 2021 | |
| W. L. Gore & Associates, INC. | $742.67 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $535.68 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cook Medical LLC | $507.42 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zenith Alpha, Zenith Spiral-Z |
| Inari Medical, INC. | $242.94 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $210.38 | 2023-2025 | Grafix Pl, Stravix Pl |
| Lifenet Health | $205.78 | 2025 | Theragenesis Wound Matrix |
| Abbott Laboratories | $155.26 | 2024 | Esprit |
| Medtronic Vascular, INC. | $86.40 | 2019 | |
| Philips North America LLC | $73.44 | 2023 | |
| Shape Memory Medical INC. | $51.57 | 2023 | Impede Embolization Plug |
| Boston Scientific Corporation | $37.85 | 2024 | Embold Fibered |
| Tactile Systems Technology INC | $24.26 | 2025 | Flexitouch Plus, Nimbl |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wyers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.